Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro

Exosomes are nano-sized membrane vesicles released from a wide variety of cells, formed in endosomes by inward budding of the endosomal limiting membrane. They have immune stimulatory-, inhibitory-, or tolerance-inducing effects, depending on their cellular origin, which is why they are investigated for use in vaccine and immune therapeutic strategies. In this study, we explored whether exosomes of different origins and functions can selectively target different immune cells in human peripheral blood. Flow cytometry, confocal laser scanning microscopy, and multispectral imaging flow cytometry (ImageStream) revealed that exosomes derived from human monocyte-derived dendritic cells and breast milk preferably associated with monocytes. In contrast, exosomes from an EBV-transformed B cell line (LCL1) preferentially targeted B cells. This was not observed for an EBV− B cell line (BJAB). Electron microscopy, size-distribution analysis (NanoSight), and a cord blood transformation assay excluded the presence of virions in our LCL1 exosome preparations. The interaction between LCL1-derived exosomes and peripheral blood B cells could be blocked efficiently by anti-CD21 or anti-gp350, indicating an interaction between CD21 on B cells and the EBV glycoprotein gp350 on exosomes. The targeting of LCL1-derived exosomes through gp350–CD21 interaction strongly inhibited EBV infection in B cells isolated from umbilical cord blood, suggesting a protective role for exosomes in regulating EBV infection. Our finding also suggests that exosome-based vaccines can be engineered for specific B cell targeting by inducing gp350 expression.

[1]  A. Harris,et al.  New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. , 2010, Blood.

[2]  Qiang Zhou,et al.  Cellular Internalization of Exosomes Occurs Through Phagocytosis , 2010, Traffic.

[3]  T. D. de Gruijl,et al.  Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.

[4]  S. Temme,et al.  The Herpes Simplex Virus-1 Encoded Glycoprotein B Diverts HLA-DR into the Exosome Pathway , 2009, The Journal of Immunology.

[5]  Laurence Zitvogel,et al.  Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα , 2009, PloS one.

[6]  S. Gabrielsson,et al.  Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. , 2009, Blood.

[7]  Willem Stoorvogel,et al.  Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. , 2009, Blood.

[8]  R. Ahmed,et al.  Requirement of B Cells for Generating CD4+ T Cell Memory1 , 2009, The Journal of Immunology.

[9]  Jaap M Middeldorp,et al.  Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. , 2008, Seminars in cancer biology.

[10]  Jun Yan,et al.  Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1. , 2008, Blood.

[11]  P. Barlow,et al.  Molecular Basis of the Interaction between Complement Receptor Type 2 (CR2/CD21) and Epstein-Barr Virus Glycoprotein gp350 , 2008, Journal of Virology.

[12]  S. Gabrielsson,et al.  Different types of in vitro generated human monocyte‐derived dendritic cells release exosomes with distinct phenotypes , 2008, Immunology.

[13]  J. Kovács,et al.  B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity. , 2008, Molecular immunology.

[14]  Sanchita Bhatnagar,et al.  Exosome Function: From Tumor Immunology to Pathogen Biology , 2008, Traffic.

[15]  Simon C Watkins,et al.  Exosomes As a Short-Range Mechanism to Spread Alloantigen between Dendritic Cells during T Cell Allorecognition1 , 2008, The Journal of Immunology.

[16]  S. Gabrielsson,et al.  B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. , 2007, The Journal of allergy and clinical immunology.

[17]  R. Roozendaal,et al.  Complement receptors CD21 and CD35 in humoral immunity , 2007, Immunological reviews.

[18]  Riitta Lahesmaa,et al.  Exosomes with Immune Modulatory Features Are Present in Human Breast Milk1 , 2007, The Journal of Immunology.

[19]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[20]  C. Théry,et al.  Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. , 2005, Blood cells, molecules & diseases.

[21]  Graça Raposo,et al.  Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.

[22]  C. Théry,et al.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. , 2005, Blood.

[23]  Aled Clayton,et al.  Adhesion and signaling by B cell‐derived exosomes: the role of integrins , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Sébastien Roy,et al.  Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. , 2004, The Biochemical journal.

[25]  A. Booth,et al.  Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway* , 2003, Journal of Biological Chemistry.

[26]  Jaap M Middeldorp,et al.  Localization of the Epstein-Barr virus protein LMP 1 to exosomes. , 2003, The Journal of general virology.

[27]  C. Théry,et al.  Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes , 2002, Nature Immunology.

[28]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[29]  Graça Raposo,et al.  The Biogenesis and Functions of Exosomes , 2002, Traffic.

[30]  M. Karlsson,et al.  "Tolerosomes" are produced by intestinal epithelial cells , 2001, European journal of immunology.

[31]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[32]  S. Knight,et al.  MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. , 1999, International immunology.

[33]  R. Frade,et al.  Binding of the endogenously expressed Epstein‐Barr virus (EBV) envelope glycoprotein gp350 with the viral receptor masks the major EBV‐neutralizing epitope and affects gp350‐specific ADCC , 1998, Journal of leukocyte biology.

[34]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[35]  D. Lyles,et al.  Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes , 1994, Journal of virology.

[36]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[37]  N. Cooper,et al.  Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice. , 1993, The American journal of pathology.

[38]  J. Bonnefoy,et al.  Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes , 1992, The Journal of experimental medicine.

[39]  G. Nemerow,et al.  Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). , 1989, The Journal of biological chemistry.

[40]  R. Johnstone,et al.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.

[41]  J. Sprent,et al.  T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. , 1987, Journal of Immunology.

[42]  P. A. Biro,et al.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Klein,et al.  Production by EBV infection of an EBNA‐positive subline from an EBNA‐negative human lymphoma cell line without detectable EBV DNA , 1975, International journal of cancer.

[44]  G. Klein,et al.  Immuno-fluorescence and immuno-electron microscopy on EBV-associated membrame antigen of a nasopharyngeal carcinoma derived lymphoblastoid cell line (LY-28). , 1974, European journal of cancer.

[45]  A. McLellan.  Exosome release by primary B cells. , 2009, Critical reviews in immunology.

[46]  M. Mason,et al.  Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. , 2001, Journal of immunological methods.